Living with chronic pain can be debilitating, but it doesn’t have to be. Recent studies have shown that adding CBD to a daily routine can help reduce pain and improve overall quality of life. In this article, we explore the potential benefits of CBD for people living with pain, as well as the results of a recent trial involving CBD and pain management. We’ll also discuss the potential risks of using CBD, and how to find the right product for your needs. By the end of this article, you’ll have a better understanding of how CBD might be able to help you manage your chronic pain.
How long does it typically take to notice the effects of CBD on physical pain?
It depends on how much CBD is taken and how often, but it usually takes about a week for users to start to feel the effects of CBD on physical pain. Depending on the severity of the pain and the individual’s response to the CBD, it can take anywhere from a few days to several weeks for the full effects to be felt.
Are there any known side effects to using CBD to treat chronic pain?
Yes, there are some known side effects to using CBD to treat chronic pain. These can include dry mouth, drowsiness, lightheadedness, and changes in appetite or weight. Additionally, some users may experience anxiety, changes in mood, or changes in concentration. It is important to consult with a doctor before beginning a CBD trial for chronic pain, to ensure that any potential side effects can be monitored and managed.
How do I know if a CBD trial is right for me?
If you are living with chronic pain, a CBD trial may be beneficial for you. CBD is known to have natural anti-inflammatory and anti-anxiety properties, which can help reduce the severity of your pain. Additionally, CBD can help reduce muscle spasms, improve sleep quality, and help you manage stress. Talk to your doctor to discuss whether a CBD trial is right for you.
What are the benefits of participating in a CBD trial for chronic pain?
Participating in a CBD trial for chronic pain can offer many benefits for those living with pain. Firstly, CBD trials may provide participants with access to treatments that are not yet available to the general public, giving them the chance to experience relief from their pain. Additionally, participating in a trial may help researchers to better understand the efficacy of CBD in treating chronic pain, leading to better treatments and improved quality of life for those living with chronic pain. Finally, participation in a CBD trial can help to provide valuable data to researchers and medical professionals, allowing them to develop more effective treatments and protocols for those living with chronic pain.
What types of chronic pain can CBD help treat?
CBD has been studied for its potential role in treating various types of chronic pain, including neuropathic pain, fibromyalgia, rheumatoid arthritis, cancer-related pain, and headaches. It is also believed to be effective in managing pain caused by multiple sclerosis and spinal cord injuries. It has been shown to be helpful in reducing inflammation and alleviating pain associated with muscle spasms, chronic nerve pain, and arthritis. In addition, CBD has been studied for its potential use in treating fibromyalgia, chronic migraines, and other forms of chronic pain. While more research is needed to understand the full extent of its efficacy, CBD has shown promise in reducing pain and improving quality of life for many individuals.
Journal of Cannabis Research volume 3 , Article number 19 Cite this article. Metrics details. Cannabidiol CBD is a primary component in the cannabis plant however, in recent years, interest in CBD treatments has outpaced scientific research and regulatory advancement resulting in a confusing landscape of misinformation and unsubstantiated health claims. Within the limited results from randomized controlled trials, and lack of trust in product quality and known clinical guidelines and dosages, real-world evidence RWE from countries with robust regulatory frameworks may fill a critical need for patients and healthcare professionals. The objective of this study is to assess the impact of CBD-rich treatment on symptom burden, as measured with a specific symptom assessment scale ESAS-r. This retrospective observational study examined pain, anxiety, depression symptoms, and wellbeing in participants over 18 years old, prescribed with CBD-rich treatment at a network of clinics dedicated to medical cannabis in Quebec, Canada. The addition of deltatetrahydrocannabinol THC during the first follow-up had no effect on symptom changes. This retrospective observational study suggests CBD-rich treatment has a beneficial impact on pain, anxiety, and depression symptoms as well as overall wellbeing only for patients with moderate to severe symptoms however, no observed effect on mild symptoms. The results of this study contribute to address the myths and misinformation about CBD treatment and demand further investigation. Cannabidiol CBD is one of the primary cannabinoids found in significant but variable concentrations in cannabinoid-based medicines CBM. This favorable safety profile has led to the recent mitigation of legal and regulatory barriers surrounding purified CBD products in several countries and recent increased interest in CBD treatments. This regulatory status imparts restrictions and access obstacles for researchers. However, the evidence of its effectiveness for indications other than drug-resistant pediatric epilepsy conditions remains very limited Larsen and Shahinas Franco et al. Randomized controlled trials RCTs are limited in their rigorous design, population sample, and duration of observation making generalization of results and long-term data scarce. Therefore, real-world evidence RWE provides valuable insights and supplemental information about the use, safety, and effectiveness of CBD-based treatments Graham et al. Symptom control is the primary reason for use of CBM, with most patients looking to address unalleviated symptoms, perceived symptom intensity, and burden on health-related quality of life independently of primary diagnosis Sexton et al. The Edmonton Symptom Assessment Scale-revised version ESAS-r is a validated scale to assess symptom burden developed for use in oncology and palliative care Hui and Bruera , it has relevance to medical cannabis care as patients are often treated for similar symptom management Good et al. Specifically, studies showed self-perceived improvement in ESAS-r emotional symptoms anxiety and depression scores following CBM treatment in oncology patients, while pain and wellbeing symptoms showed no improvement Good et al. In addition, although careful titration and treatment adjustment after initiation is critical to symptom improvement and adverse effects care, current literature has failed to address this issue. In this study, we investigated treatment with CBD-rich products within a dedicated clinical setting in Quebec, Canada, and the effects on a very common clinical symptom expression of pain and comorbid anxiety and depression symptoms, as well as the effect on overall wellbeing. This study is a retrospective examination of patients who were prescribed CBD-rich products by physicians at a clinic dedicated to CBM treatments operating at four locations across Quebec, Canada. All data are collected as part of standard clinical procedures during the initial visit and during 3 FUP1 and 6 FUP2 month follow-up visits and extracted from electronic medical records EMR Prosk et al. All data were anonymized following extraction from the EMR and no identifiers linking to original data were maintained. Adult patients, at least 18 years of age, who were initially treated exclusively with CBD-rich products from 1 October to 31 May and for whom outcome scores and product information were recorded at FUP1 were included in this study. Patients were generally referred by primary-care physicians and specialists for an assessment on the suitability of medical cannabis to treat refractory symptoms. A complete medical history, including primary and secondary diagnoses, was collected at baseline visit.
